EC Grants CE Mark to InSightec’s Exablate Prostate System

Israel-based InSightec received the CE Mark for its Prostate Exablate system for the management of prostate cancer locally confined with MRI — guided focused ultrasound.

The device uses focused ultrasound waves to target and destroy specific tissue in the prostate.

The treatment is performed under magnetic resonance for high resolution visualization of the patient's anatomy as well as real-time temperature control.

The treatment does not require incisions and is performed in one visit. — Cynthia Jessup